D-Wave Quantum (QBTS) Achieves Successful US$400 Million Equity Offering
Every company has risks, and we've spotted 4 warning signs for D-Wave Quantum (of which 1 is potentially serious!) you should know about.
Uncover the next big thing with financially sound penny stocks that balance risk and reward.
Over the past year, D-Wave Quantum's shares have experienced a very large increase of 1751.96%, highlighting substantial long-term shareholder returns. In comparison to the US Software industry and the broader US market, which returned 26.3% and 14.8% respectively over the past year, D-Wave's performance has been exceptional.
The considerable capital infusion from the $400 million equity offering mentioned in the introduction might aid in supporting D-Wave's revenue growth, which is forecasted to increase by 35% annually. However, despite recent share price surges and a closing price of $18.89, the current share price exceeds the consensus analyst price target of $16.57, indicating a potential overvaluation relative to market expectations. This price movement, juxtaposed with the company's ongoing unprofitability, raises questions about earnings forecasts in the near term.
Learn about D-Wave Quantum's future growth trajectory here.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include QBTS.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
SergeFerrari Group: Revenue of €178.7 Million in the First Half of 2025
Continued sales momentum in the 2nd quarter of 2025 Growth exceeds 10% in the first six months of 2025 SAINT-JEAN-DE-SOUDAIN, France, July 29, 2025--(BUSINESS WIRE)--Regulatory News: SergeFerrari Group (FR0011950682 – SEFER), SergeFerrari Group (FR0011950682 - SEFER), a leading global supplier of innovative flexible composite materials, listed on Euronext Paris – Compartment C, today announced its revenues for the first half of 2025. Breakdown of sales by geographic area (unaudited) (€ thousands) 2ndquarter2025 2ndquarter2024 Ch. atcurrentscope andexchangesrates Ch. atconstantscope andexchangesrates H1 2025 H1 2024 Ch. atcurrentscope andexchangesrates Ch. atconstantscope andexchangesrates Europe 69,068 66,730 +3.5% +3.2% 128,589 120,519 +6.7% +6.5% Americas 14,979 8,325 +79.9% +86.4% 23,399 16,003 +46.2% +48.7% Asia – Africa – Pacific 15,512 13,387 +15.9% +16.0% 26,743 25,382 +5.4% +5.4% Total revenues 99,558 88,442 +12.6% +13.0% 178,731 161,904 +10.4% +10.5% Sébastien Baril, SergeFerrari Group's chairman of the Executive Board, stated: "Signs of improvement in our historic markets are gradually materializing. Serge Ferrari recorded an increase in revenues of over 10% in the first half of the year. This performance encourages us to continue our efforts to increase our operating leverage, our customer service and the flexibility of our cost structure in an environment where adaptability and responsiveness remain key." Q2 2025 activity The Group reported revenue of €99.6 million in the 2nd quarter of 2025, up 12.6% on a current scope and exchange rate basis, and up 13.0% on a constant scope and exchange rate basis compared with the same period last year. This change is due to: A currency effect of -0.4 %; A volume effect of -3.0%, due mainly to a fall in volumes of modular structures, for which the end markets are declining; A favorable price-mix effect of +16.0%, driven by a confirmed recovery in activities that have traditionally been profitable for the Group, such as Solar Protection and the new Solutions business lines, as well as the impact of price increases introduced to mitigate the negative effect of high inflation on certain raw materials. H1 2025 activity The Group posted sales of €178.7 million in the first half of 2025, up by more than 10% on both current and constant scopes and exchange rates. Half-year sales trends by geographical region are as follows: Europe posted solid revenue growth of 6.7% on a current scope and exchange rate basis and 6.5% on a constant scope and exchange rate basis, with sales of almost €129 million over the period, thanks to historic markets that remain well oriented. After a difficult 2024 exercise in North American markets, sales in the Americas rebounded strongly in the first half. Growth accelerated sharply between the 1st and 2nd quarters, taking half-year sales up to €23.4 million, representing growth at constant scope and exchanges rates of +49%. Sales in the Asia-Africa-Pacific region were up 5.4% on H1 2024, both on a current and constant scope and exchange rates basis, due to good momentum in the various markets. Outlook Based on a seasonal history between the first (driven by solar protection activity and tense architecture) and the second half of the fiscal year, the group will focus (despite an uncertain context, particularly on the geopolitical level) on maintaining its trajectory initiated with Transform 2025 that aims at increasing its adaptability and profitability. Financier calendar Publication of first half 2025 results on September 10, 2025, after market close. ABOUT SERGEFERRARI GROUP The Serge Ferrari Group is a leading global supplier of composite materials for Tensile Architecture, Modular Structures, Solar Protection and Furniture/Marine, in a global market estimated by the Company at around €6 billion. The unique characteristics of these products enable applications that meet the major technical and societal challenges: energy-efficient buildings, energy management, performance and durability of materials, concern for comfort and safety together, opening up of interior living spaces etc. Its main competitive advantage is based on the implementation of differentiating proprietary technologies and know-how. The Group has manufacturing facilities in France, Switzerland, Germany, Italy and Asia. Serge Ferrari operates in 80 countries via subsidiaries, sales offices and a worldwide network of over 100 independent distributors. At the end of 2024, SergeFerrari Group posted consolidated revenues of €323.6 million, more than 80% of which was generated outside France. SergeFerrari Group is listed on Euronext Paris – Compartment C (ISIN code: FR0011950682). SergeFerrari Group shares are eligible for the PEA-PME and FCPI investment schemes. View source version on Contacts Valentin Chefson Head of Relations Investisseursinvestor@ NewCap Investor Relations – Financial Communication Théo MartinTel. : 01 44 71 94 94sferrari@
CNBC
2 hours ago
- CNBC
The best ways to play the emergence of quantum computing, according to Rosenblatt
Investors wanting to get in early on the emerging space of quantum computing might want to consider D-Wave and IonQ , according to Rosenblatt analyst Kevin Garrigan. He initiated the two quantum computing stocks with buy ratings and a price target of $30 for D-Wave and $70 for IonQ. Those predictions imply gains of about 64% or more for both stocks from their latest close. "Quantum computing promises to solve certain classes of problems that are intractable for even the most advanced classical supercomputers," Garrigan wrote in a Monday note to clients. "While widespread quantum advantage is still several years away, targeted applications in optimization, quantum chemistry, and cybersecurity are already driving early enterprise adoption," Garrigan continued. "We believe companies demonstrating near-term commercial traction through hybrid quantum-classical solutions while also monitoring long-term disruptive plays in cryptography and AI acceleration as quantum hardware scales is important." A handful of quantum stocks have already seen a sharp run-up their valuations this year as investors bet on the fast-growing technology and companies innovate quantum computing chips and systems . Volatility persists as quantum computing remains in its infancy, but bulls remain focused on its ultimate potential to revolutionize functions across industries. D-Wave is up more than 122% year to date, after rallying 1,812% over the past 12 months. IonQ has added just 3.6% in 2025, but has surged more than 452% over the past year. Rigetti Computing , another quantum computing play , is up nearly 2% year to date but has rallied roughly 41% over the past month. Rigetti shares have surged 1,458% over the past year, according to FactSet. IonQ, which went public via SPAC in 2021, expects quantum to achieve broad commercial application by 2030, Garrigan said. "IonQ is a leading pure-play public company specializing in trapped-ion quantum computing, leveraging atomic ions suspended in electromagnetic fields as qubits," the analyst wrote. "Known for their long coherence times, high fidelity, and full qubit connectivity, trapped-ion systems offer architectural advantages but face challenges with slower gate speeds and scaling laser control as qubit counts increase." IonQ has made several acquisitions in recent years, bolstering its own capabilities in quantum internet infrastructure, he added. QBTS 1Y mountain D-Wave stock performance over the past year. D-Wave is known to deploy quantum computing technology that is energy-efficient. Upon initiating the stock, Garrigan highlighted that D-Wave uniquely specializes in quantum annealing systems, which he said solve "large-scale optimization problems by evolving a system to its lowest energy state." "Unlike gate-based quantum computers, D-Wave's annealers excel at problems with complex variables and constraints, offering significant energy efficiency advantages — claiming up to 1,000x reduction in compute power for tasks like hashing," he said. D-Wave in late May announced its most advanced quantum computing system , Advantage2, and said the computer offers a 40% boost in energy scale and can use fewer qubits to solve problems. Additionally, Garrigan noted a significant jump in venture capital investment over the past decade that has encouraged the rise of quantum startups and investor enthusiasm. He highlighted private players such as Alice & Bob and IQM Quantum Computers alongside megacap tech companies IBM and Google that are also making developments in the field.
Yahoo
5 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
